Reviva Pharmaceuticals/$RVPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Reviva Pharmaceuticals
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
Ticker
$RVPH
Sector
Primary listing
Employees
14
Headquarters
Website
RVPH Metrics
BasicAdvanced
$9.3M
-
-$5.48
-
-
Price and volume
Market cap
$9.3M
52-week high
$3.52
52-week low
$0.59
Financial strength
Current ratio
2.076
Quick ratio
1.985
Total debt to equity
4.705
Interest coverage (TTM)
-1,507.24%
Profitability
Effective tax rate (TTM)
-0.10%
Management effectiveness
Return on assets (TTM)
-80.35%
Return on equity (TTM)
-419.97%
Valuation
Price to book
0.5
Price to tangible book (TTM)
0.5
Price to free cash flow (TTM)
-0.108
Free cash flow yield (TTM)
-929.11%
Free cash flow per share (TTM)
-6.779
Growth
Earnings per share change (TTM)
-69.64%
3-year earnings per share growth (CAGR)
-42.59%
RVPH News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Reviva Pharmaceuticals stock?
Reviva Pharmaceuticals (RVPH) has a market cap of $9.3M as of April 01, 2026.
What is the P/E ratio for Reviva Pharmaceuticals stock?
The price to earnings (P/E) ratio for Reviva Pharmaceuticals (RVPH) stock is 0 as of April 01, 2026.
Does Reviva Pharmaceuticals stock pay dividends?
No, Reviva Pharmaceuticals (RVPH) stock does not pay dividends to its shareholders as of April 01, 2026.
When is the next Reviva Pharmaceuticals dividend payment date?
Reviva Pharmaceuticals (RVPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Reviva Pharmaceuticals?
Reviva Pharmaceuticals (RVPH) does not currently have a Beta indicator.